| Absorption |
| Blood-Brain Barrier | BBB+ | 0.6588 |
| Human Intestinal Absorption | HIA+ | 0.9972 |
| Caco-2 Permeability | Caco2+ | 0.7904 |
| P-glycoprotein Substrate | Substrate | 0.5199 |
| P-glycoprotein Inhibitor | Inhibitor | 0.5819 |
| Non-inhibitor | 0.8202 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8760 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6198 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8299 |
| CYP450 2D6 Substrate | Non-substrate | 0.8408 |
| CYP450 3A4 Substrate | Substrate | 0.6607 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9079 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.7723 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9368 |
| CYP450 2C19 Inhibitor | Inhibitor | 0.5225 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8808 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6267 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9273 |
| Non-inhibitor | 0.8259 |
| AMES Toxicity | Non AMES toxic | 0.8391 |
| Carcinogens | Non-carcinogens | 0.7489 |
| Fish Toxicity | High FHMT | 0.7396 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9471 |
| Honey Bee Toxicity | High HBT | 0.8389 |
| Biodegradation | Not ready biodegradable | 0.9655 |
| Acute Oral Toxicity | III | 0.7696 |
| Carcinogenicity (Three-class) | Non-required | 0.5753 |